CRKL peptide product blog
Tags: Peptide; CRKL; CRKL peptide;
The CRKL crkl (Catalog #MBS425568) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. The CRKL Immunizing Peptide reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet.The CRKL crkl product has the following accession number(s) (GI #4885153) (NCBI Accession #NP_005198.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful. The amino acid sequence is listed below:
C-KIFDPQNP DENE.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
CRKL also interacts with the following gene(s): ABL1, BCAR1, BCR, CBL, GAB1, MAP4K1, NEDD9, PXN. Breast Neoplasms, Carcinoma, Hepatocellular, Cardiovascular Diseases, Cell Transformation, Neoplastic, DiGeorge Syndrome, Disease Models, Animal, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lung Diseases, Lung Neoplasms are some of the diseases may be linked to CRKL Immunizing Peptide. The following patways have been known to be associated with this gene. Blood, Bone, Bone Marrow, Brain, Embryonic Tissue, Heart, Liver, Lung, Lymph Node, Nerve tissues are correlated with this protein.